Nventa Strengthens Management Team With Vice President Of Finance

    -- David Duncan, Jr. Has Significant Financial Experience in
    Biotechnology --

    SAN DIEGO, CA, Sept. 12 /CNW/ - Nventa Biopharmaceuticals Corporation
(TSX:NVN) announced today that David Duncan, Jr., has joined the Company as
its Vice President of Finance.
    "With his successful track record serving biotechnology companies, we are
very pleased to welcome David to Nventa," said Gregory M. McKee, President and
Chief Executive Officer of Nventa. "His extensive experience in financial and
operations management, including public stock offerings, financial reporting,
investor relations, treasury and cash management, should prove invaluable as
we advance our lead therapeutic vaccine candidate, HspE7, and other future
CoVal(TM) fusion products."
    Mr. Duncan has extensive experience in financial and operations
management, and has been involved with several successful biotechnology
companies including La Jolla Pharmaceutical Company, Tanox, Inc. and Hybritech
Incorporated. Mr. Duncan received his bachelor's degree in Finance and his MBA
at Indiana University in Bloomington, Indiana.

    About Nventa Biopharmaceuticals Corporation:
    Nventa is developing innovative therapeutics for the treatment of viral
infections and cancer, with a focus on diseases caused by the human
papillomavirus (HPV). The Company is publicly traded on the Toronto Stock
Exchange under the symbol NVN. For more information about Nventa
Biopharmaceuticals Corporation, please visit the Company's website located at
    %SEDAR: 00023483E

For further information:

For further information: Donna Slade, Director, Investor Relations, 9381
Judicial Drive, Suite 180, San Diego, CA, USA 92121, Dir: (858) 202-4945,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890